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Abstract
Background: Esophageal schwannomas are rare primary submucosal esophageal tumors. We herein report a case
of an esophageal schwannoma that was difficult to diagnose.
Case presentation: A 39-year-old woman presented with chief complaints of difficulty swallowing and epigastric
pain. Enhanced computed tomography of her chest revealed a tumor mass at the upper thoracic esophagus with
internal heterogeneity. 18-Fluorodeoxyglucose positron emission tomography/computed tomography showed a
hypermetabolic appearance matching the tumor mass; the accumulation had a maximum standardized uptake
value of 5.5. We performed endoscopic ultrasound-guided fine-needle aspiration biopsy under general anesthesia,
but the small specimens obtained prevented a definitive diagnosis. Thoracoscopic esophagectomy was performed
due to the large size of the tumor, suspicion of its malignant potential, and the patient’s symptoms.
Histopathological examination revealed spindle-shaped cells in a fasciculated and disarrayed architecture in the
proper muscle layer. Immunohistochemical studies showed S100 protein positivity and the absence of CD34 and
c-kit. We diagnosed the tumor as a benign schwannoma.
Conclusions: We herein report a relatively rare case of schwannoma of the esophagus that was diagnosed with
difficulty.
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Background
The incidence of benign primary tumors of the esopha-
gus is low. The most common histological type is
leiomyoma; the incidence of schwannoma among benign
tumors is low [1–5]. Esophageal schwannomas are
difficult to definitively diagnose by biopsy because they
are located in the submucosal tissue.
18-Fluorodeoxyglucose positron emission tomography
(FDG-PET) has been used to detect metabolism of
glucose by tumors. High FDG uptake is generally found
in malignant tumors; it is also found in inflammation.
Although they are benign tumors, schwannomas report-
edly show a hypermetabolic appearance on FDG-PET
[6–8]. We previously reported the utility of FDG-PET
for diagnosis of schwannoma of the stomach [9].
In general, surgical resection of esophageal submuco-
sal tumors is dependent upon the tumor size, malignant
potential, and patient’s symptomatic state. Although the
final diagnosis must be obtained surgically, as in the
present case, minimally invasive thoracoscopic surgery is
considered to be an appropriate technique for esopha-
geal submucosal tumors.
Case presentation
A 39-year-old woman presented for evaluation of diffi-
culty swallowing and epigastric pain. Her medical and
familial histories were unremarkable. Upper gastrointes-
tinal endoscopy showed a smooth elevated lesion located
19 to 24 cm from the incisor teeth (Fig. 1). Endoscopic
ultrasonography showed a large tumor mass of low
echogenicity in the esophageal wall. The tumor mass
originated in the muscle layer, and we performed a
boring biopsy of the tumor mass. However, we were
unable to obtain a tissue specimen from the tumor.
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A chest enhanced computed tomography (CT) scan
revealed a tumor mass (39 × 28 × 56 mm) at the upper
thoracic esophagus with internal heterogeneity. No metas-
tasis to the lymph nodes or other organs was seen on the
CT scan (Fig. 2a). FDG-PET CT showed a hypermetabolic
appearance matching the tumor mass. The maximum
standardized uptake value (max SUV) was 5.5 (Fig. 2b).
Magnetic resonance imaging of the chest revealed that
the boundary of the tumor was clear and smooth. The
mass exhibited isointensity or low intensity compared
with the muscles on T1-weighted images and high inten-
sity on T2-weighted images. There was no invasion into
the surrounding tissue.
We performed endoscopic ultrasound-guided fine-
needle aspiration biopsy (EUS-FNAB) with the patient
under general anesthesia. Because the specimen was
small, we were unable to establish a definitive diagnosis.
We suspected an esophageal schwannoma, leiomyoma,
or gastrointestinal stromal tumor (GIST).
The patient underwent surgery because of her difficulty
swallowing and our suspicion of malignant potential. We
performed thoracoscopic surgery with the patient under
general anesthesia and single-lung ventilation.
First, we attempted enucleation of the tumor. How-
ever, the mass was larger than 5 cm, and enucleation
was difficult without creating an extensive defect of the
esophageal wall. Therefore, subtotal esophagectomy was
performed with thoracoscopic assistance.
The resected specimen measured 55 × 45 × 24 mm. The
cut surface was solid milky white (Fig. 3a). Histopatho-
logical examination revealed spindle-shaped cells in a
fasciculated and disarrayed architecture in the proper
muscle layer. Immunohistochemical studies showed S100
protein expression and the absence of CD34 and c-kit
protein expression. Nuclear division was inconspicuous,
and the MIB-1 labeling index was <10 %. Finally, we
diagnosed the tumor as a benign schwannoma. The
patient’s postoperative course was uneventful, and she had
no evidence of recurrence at the time of this writing.
Conclusions
Benign primary tumors of the esophagus account for less
than 1 % of all esophageal tumors [1]. The most com-
mon benign submucosal esophageal tumor is leio-
myoma. According to previous reports, leiomyoma
accounts for more than half of all benign esophageal tu-
mors [1, 2]. Benign submucosal esophageal tumors also
include lipomas, granular cell tumors, and schwanno-
mas. A GIST is an esophageal submucosal tumor with
malignant potential.
A few cases of primary esophageal schwannomas have
been reported [3, 4]. Gastrointestinal schwannomas
account for 0.4 to 1.0 % of all submucosal tumors of the
gastrointestinal tract. Most occur in the stomach; the
development of a schwannoma in the esophagus is
uncommon [4].
The definitive diagnosis of an esophageal submucosal
tumor should be made before tumor excision to avoid
unnecessary surgery. However, the preoperative patho-
logical diagnosis of a submucosal tumor is unclear in
some cases. As in the present case, an adequate specimen
is difficult to obtain during biopsy of a submucosal tumor,
even if a boring biopsy is performed. This is because the
Fig. 1 Endoscopic findings. This endoscopic photograph demonstrates
the submucosal tumor of the esophagus. It occupied the most of the
esophageal lumen
Fig. 2 CT and FDG-PET CT findings. a Computed tomography revealed
a large isodense mass of the esophageal wall in the upper mediastinal
space. b Accumulation of fluorodeoxyglucose is demonstrated in the
upper thoracic esophagus
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surface of the submucosal tumor is often covered with
normal epithelium. EUS-FNAB is now commonly per-
formed to diagnose submucosal tumors. This technique
obtains more adequate specimens than does biopsy with
upper gastrointestinal endoscopy. Rong et al. [5] reported
that the diagnostic accuracy of EUS-FNAB for submucosal
tumors was 85.2 % [5]. However, as in our case, EUS-
FNAB does not always allow for a definitive pathological
diagnosis. We are unsure of the reason for the lack of an
adequate specimen in our case. However, a puncture at an
acute angle was required to reach the deep portion of the
esophageal wall. EUS-FNAB might have been a potentially
dangerous procedure in our case because the aortic artery
and trachea are located behind the esophagus in the
mediastinal space. This may have contributed to the diffi-
culty obtaining the EUS-FNAB specimen in our case. We
proposed that the patient undergo EUS-FNAB a third
time, but she refused.
Because the preoperative pathological diagnosis was
not clear in our case, we performed subtotal thoraco-
scopic esophagectomy to both treat the patient’s symp-
toms and possibly diagnose a malignancy. Even if the
tumor mass had been a malignancy such as a GIST, the
operation would have been curative because we per-
formed subtotal esophagectomy.
Although the final diagnosis in this case was a benign
schwannoma, FDG-PET showed a hypermetabolic
appearance, suggesting malignant potential. Schwannomas
are benign tumors, but a hypermetabolic appearance on
FDG-PET has been reported. Schwannomas originate
from nerve cells that express glucose transporter type 3
[7], and FDG uptake is considered to be increased for this
reason. Beaulieu et al. [7] reported that there was no
correlation between FDG uptake and the proliferation rate
(Ki-67 index). The authors stated that even if the max
SUV is >6.0, a benign schwannoma cannot be excluded.
Our case does not conflict with their report in that our
benign schwannoma showed a max SUV of 5.5 and MIB-
1 labeling index of 10 %. Therefore, FDG-PET could not
reveal whether the hypermetabolic appearance indicated a
benign or malignant tumor. Otherwise, the findings can
be meaningful for a diagnosis of schwannoma.
There is no consensus regarding the surgical treatment
of esophageal submucosal tumors. Although the stom-
ach and esophagus differ, the clinical practice guidelines
for GIST in Japan declare that surgery is indicated for
gastric submucosal tumors larger than 5.0 cm [10]. In
our department, we first perform boring biopsy or EUS-
FNAB to obtain a histopathological diagnosis of the
submucosal tumor. If the submucosal tumor is malig-
nant, such as a GIST, we usually perform a surgical
operation. When the histopathological diagnosis is a
benign lesion or is unclear, as in the present case, we
perform one of the several approaches. If the tumor is
Fig. 3 Representative photomicrographs of tissue sections. a Massive white tumor mass in the submucosal layer. b High-power photomicrograph
of the tumor shows spindle-shaped cells in a fasciculated and disarrayed architecture (hematoxylin–eosin, ×400). c S-100 was detected in the
cytoplasm of the tumor cells (×100). d C-kit was not detected in the tumor cells (×100).
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small or asymptomatic, we usually perform simple
follow-up of the patient. When the tumor is large, in-
creasing in size, or symptomatic, we consider invasive
treatment with curative intent.
We usually first try endoscopic treatment for small
tumors originating in the submucosal layer. We then
attempt enucleation by a thoracoscopic approach
because it is less invasive. If the defect of the esophageal
wall is expected to be large upon intraoperative examin-
ation or the mass has malignant potential, we perform
an extended operation based on the individual patient.
In this case, we considered open subtotal esophagectomy
when the tumor was diagnosed as malignancy or it was
difficult to resect it safely and radically.
Thoracoscopic surgery is becoming common [8]. In
our department, we believe that thoracoscopic surgery is
a good technique for the treatment of benign tumors
because it is less invasive and clinically appropriate,
especially for benign esophageal tumors. Compared with
conventional operations, thoracoscopic esophagectomy
for esophageal submucosal tumors is reportedly associ-
ated with fewer postoperative complications such as
pneumonia and allows for earlier ambulation [11–13].
We selected the thoracoscopic approach to improve our
patient’s quality of life and performed subtotal esopha-
gectomy with curative intent.
In conclusion, we have reported a relatively rare case
of an esophageal schwannoma. The diagnosis was diffi-
cult because we could not obtain an adequately sized
specimen by boring biopsy and EUS-FNAB. The thora-
coscopic approach is a good treatment option for large
submucosal tumors of the esophagus.
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